1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. New York >
  6. Biocodex USA Acquires Hilma

Add-on Acquisition • Life Science

Biocodex USA Acquires Hilma

On November 17, 2022, Biocodex USA acquired life science company Hilma

Acquisition Context
  • This is Biocodex USA’s 3rd transaction in the Life Science sector.
  • This is Biocodex USA’s 2nd transaction in the United States.
  • This is Biocodex USA’s 1st transaction in New York.

Explore All 3110 Add-on Acquisition Life Science Deals - Search the Database Free


M&A Deal Summary
Date November 17, 2022
Target Hilma
Sector Life Science
Buyer(s) Biocodex USA
Deal Type Add-on Acquisition

Target Company

Hilma

New York, New York, United States
Hilma makes natural remedies that actually work for health issues like digestion, head tension, immune support, and more. The company makes natural remedies accessible to the mainstream customer, who has embraced natural products in food, beauty, and household items, and is looking for an effective natural option for their medicine cabinet. Hilma is entirely female-founded and led. Hilma was formed in 2020 and is based in New York, New York.
Explore More Deals

Browse All 215,158 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Biocodex USA

Redwood City, California, United States
Category Company
Founded 1953
Sector Life Science
DESCRIPTION

Biocodex USA is an independent multinational pharmaceutical company, dedicated to providing its customers with meaningful health care solutions, with an emphasis on gastroenterology and oncology supportive care.

Deal Context for Buyer #
Overall 3 of 4
Sector: Life Science 3 of 4
Type: Add-on Acquisition 2 of 2
State: New York 1 of 1
Country: United States 2 of 2
Year: 2022 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-11-18 Laboratoires IPRAD

Paris, France

Laboratoires IPRADParis is a pharmaceutical company. Feminine Care, with the brands Saforelle®, Mucogyne®, Gestarelle®, Physioflor®, and gynecological drugs like Secnol® and Gydrelle®. Laboratoires IPRAD was founded in 1989 and is based in Paris, France.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2025-09-04 MRM Health

Gent, Belgium

MRM Health is a clinical-stage biotech developing innovative microbiome-based therapeutics for inflammatory diseases and immune-oncology. MRM Health is based in Gent, Belgium.

Buy -

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - New York M&A - United States M&A - 2022 M&A

Mergr

Solution for

Product

Company

Legal